Advances in Lymphoid Disorders: Immunological Insights and Therapeutic Innovations
A special issue of Lymphatics (ISSN 2813-3307).
Deadline for manuscript submissions: 31 October 2025 | Viewed by 75
Special Issue Editor
Interests: interferons; cancer; innate immunity; adaptive immunity; skin; inflammation
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Lymphoid disorders refer to diseases that affect the lymphoid system, which includes lymph nodes, spleen, thymus, bone marrow, and lymphoid tissues associated with mucosal surfaces. These disorders can be broadly classified into benign (non-cancerous) and malignant (cancerous) conditions. Advances in lymphoid disorders, including lymphomas, leukemias, and other immune-related malignancies, have been significant in recent years. The landscape of lymphoid disorders is rapidly evolving with breakthroughs in personalized medicine, improving patient survival and quality of life. The future holds promise for even more refined, less toxic, and highly effective treatment options, thanks to advances in diagnostics, targeted therapies, immunotherapies, bone marrow transplantation, liquid biopsies for disease monitoring, and our understanding of disease biology, among others.
This Special Issue is expanding current knowledge on advances in lymphoid disorders. Experimental studies in in vivo models, review articles, and clinical studies are all welcome for publication.
Dr. Nabiha Yusuf
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Lymphatics is an international peer-reviewed open access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- lymphoid disorders
- immunotherapy
- therapeutics
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
